4SC to Present at the Jefferies 2010 Global Life Sciences Conference and the Piper Jaffray 5th Annual Europe Conference

(PresseBox) ( Planegg-Martinsried, )
4SC AG (Frankfurt, Prime Standard: VSC) a drug discovery and development company focused on autoimmune and cancer indications, today announced that Ulrich Dauer, CEO of 4SC, will be presenting at the following investor conferences:

Jefferies 2010 Global Life Science Conference
New York, USA
11 June, 2010
10am EDT

Piper Jaffray 5th Annual Europe Conference
London, UK
22 June, 2010
5.30pm BST
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.